LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway

Abstract

Pancreatic cancer (PC) is a common type of malignancy originating from the epithelium of the pancreatic duct, with the most lethal feature and worst prognosis. LEM domain containing 1 (LEMD1) is overexpressed in multiple tumor tissues and plays a key role in cancer carcinogenesis and progression. However, little is known about the potential of LEMD1 in PC. In this study, we explored the clinical values, as well as the potential roles and mechanisms of LEMD1 in PC. We, for the first time, showed that LEMD1 was upregulated in PC and negatively correlated with the overall and disease-free survival of patients with PC. Of the function, LEMD1 knockdown inhibited cancer cell growth, migration and invasion, while LEMD1 overexpression promoted tumor aggressiveness. The tumor-promoting influences of LEMD1 in PC were also proved by in vivo assays. Mechanistically, GSEA identified that LEMD1 promoted PC aggressiveness, as well as affecting cell cycle dysregulation and apoptosis resistance, by p53 suppression and the activation of the mTORC1 signal pathway. In short, LEMD1 could serve as a valuable prognostic candidate and a potential therapeutic target of PC. Abbreviations : ATCC: American Type Culture Collection; CCK-8: Cell counting kit 8; CDK: Cyclin-dependent kinases; CTA: Cancer-testis antigen; DMEM: Dulbecco’s Modified Eagle’s Medium; ECL: enhanced chemiluminescence; FBS: Fetal bovine serum; GEO: Gene Expression Omnibus; LEMD1: LEM domain containing 1; mTOR: mammalian target of rapamycin; NC: Negative control; PC: Pancreatic cancer; PVDF: Polyvinylidene difluoride membranes; qRT-PCR: Quantitative real-time polymerase chain reaction; SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis; SD: Standard deviation; SKP2: S-Phase kinase-associated protein 2; TAA: Tumor-associated antigen; TBST: Tris-buffered Saline Tween-20; TCGA: The Cancer Genome Atlas.

Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of Picrorhizae Rhizoma Extract

“…In human cytomegalovirus infection, there is association of CCR5Δ32 deletion and human cytomegalovirus infection with colorectal cancer in Tunisia [61]. Kaposi sarcoma-associated herpesvirus infection regulates proliferation of glioma stem-like cells [62], relieves the Warburg effect through p53 activation, thereby inhibiting breast cancer cell growth [63], inhibits renal cancer cell growth by regulating the p53 signaling pathway [48], suppresses lung cancer growth by activating the p53 signaling pathway [64], promotes cholangiocarcinoma cell proliferation, migration, and invasion by decreasing p53 expression [65], and promotes pancreatic cancer growth and metastasis through the p53 transcriptional pathway [66]. In addition, th17 cells play a key role in autoimmunity and their cell differentiation contributes greatly to the treatment of cancer.…”

CENPN contributes to pancreatic carcinoma progression through the MDM2-mediated p53 signaling pathway

“…Among them, Hamada et al mentioned in their research that mitotic spindle assembly might be a common feature of lung cancer and PAAD [31]. Cao et al found that the gene could affect the cell growth process of PAAD by inhibiting p53 and activating the mTORC1 signaling pathway when exploring the mechanism of LEMD1 in PAAD [32]. Zhang et al observed that loss of IL17/IL17R signaling led to growth inhibition of PAAD [33].…”

SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis

“…Normal human thyroid (Nthy-ori 3–1) and PTC (TPC-1 and B-CPAP) cell lines were purchased from Procell (Wuhan, China). The cells were cultured in a standard incubator at 37°C with 5% CO 2 in RPMI-1640 (Gibco; Thermo Fisher Scientific, Waltham, MA, USA) with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin [ 20 ]. The cells were treated with actinomycin D (2 μg/mL; Sigma-Aldrich, St. Louis, MO, USA) to analyze the mRNA stability.…”